Gastroparesis Market Report: Size, Share, Trend, Segmentation And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Gastroparesis Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $8.19 billion In 2028 At A CAGR Of 4.8%.

The gastroparesis market size has grown strongly in recent years. It will grow from $6.44 billion in 2023 to $6.8 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to aging population, increasing prevalence of diabetes, improved understanding of gastrointestinal disorders, evolving treatment protocols, growing awareness about gastroparesis.

The gastroparesis market size is expected to see steady growth in the next few years. It will grow to $8.19 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to development of novel therapeutic options, expansion of personalized medicine approaches, integration of digital health solutions, rise in healthcare infrastructure, increasing focus on early diagnosis. Major trends in the forecast period include advancements in gastric electrical stimulation therapy, growing research in stem cell therapy, adoption of minimally invasive surgical interventions, increased use of wearable health monitoring devices, focus on patient-centric care models.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Gastroparesis Market Major Segments
The gastroparesis market covered in this report is segmented -

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies
2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types
3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Key Driver - Gastroparesis Treatment Gains Momentum With Rising Cases

The increasing prevalence of gastroparesis is expected to propel the growth of the gastroparesis market. Gastroparesis is a medical condition that stops or delays food movement from the stomach to the small intestine. Hypothyroidism, autoimmune diseases, injury to the vagus nerve, and viral stomach infections cause gastroparesis. Gastroparesis medicine tightens and contracts the muscles in the stomach wall and improves gastric emptying. For instance, in 2021, according to a research study published by Practice Update, a Netherlands-based online publisher of research articles, in 2021 the overall prevalence rate of gastroparesis was 267.7 per 100,000 persons in the US. The prevalence rate of definite gastroparesis was 21.5 per 100,000 persons. As a result, the increasing prevalence of gastroparesis is driving the growth of gastroparesis treatment.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12189&type=smp

Prominent Trend - New Devices Transforming Gastroparesis Management

Major companies operating in the gastroparesis market are developing innovative devices to increase their profitability in the market. Devices for the treatment of gastroparesis are medical tools or equipment designed to help manage or alleviate symptoms associated with gastroparesis, a condition characterized by delayed emptying of the stomach. For instance, in 2022, Enterra Medical Inc., a US-based medical device company launched enterra therapy for the treatment of gastroparesis. The Enterra Therapy system employs an implanted neurostimulator to produce gentle electrical pulses, offering potential relief for symptoms of chronic nausea and vomiting linked to gastroparesis. This therapy is designated for individuals aged 18 to 70 years experiencing chronic, intractable (drug-refractory) nausea and vomiting associated with gastroparesis of diabetic or idiopathic origin.

Gastroparesis Market Players
Major companies operating in the gastroparesis market report are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Novo Nordisk AS, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Orexo AB, Theravance Biopharma Inc., RQI Partners LLC., RedHill Biopharma Ltd., Synthorx Inc., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the gastroparesis market in 2023. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Gastroparesis Market Report Structure
3. Gastroparesis Market Trends And Strategies
4. Gastroparesis Market - Macro Economic Scenario
5. Gastroparesis Market Size And Growth
…..
27. Gastroparesis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.